期刊文献+

法舒地尔对急性冠状动脉综合征患者心肌保护作用 被引量:1

下载PDF
导出
摘要 急性冠状动脉综合征(ACS)再灌注心肌治疗有效治疗方法为经皮冠状动脉介入治疗(PCI),患者术后易出现无复流现象,其发生率5%-50%,患者心外膜冠状动脉灌注良好,心肌灌注不良,存在早期梗死后并发症风险。目前对微循环无复流防治缺乏有效治疗药物,法舒地尔为临床应用的Rho激酶抑制剂,研究证实对包括冠状动脉痉挛、冠脉再通手术后的再狭窄、PCI术中发生无复流均具有很好的治疗作用和安全性,本研究旨在对ACS患者PCI治疗中出现无复流后应用法舒地尔与传统药物硝酸甘油及合心爽对比,观察对患者的心肌组织保护及临床预后的作用。
出处 《中国实验诊断学》 2015年第7期1160-1162,共3页 Chinese Journal of Laboratory Diagnosis
基金 长春市科委资助项目(12SF70)
  • 相关文献

参考文献14

  • 1Hong YJ, Jeong MH, Choi YH, et al. Impact of plaque compo- nents on no-reflow phenomenon after stent deployment in patients with acute coronary syndrome., a virtual histology-intravascular ultrasound analysis[J]. Eur Heart J, 2011,32 : 2059. 被引量:1
  • 2陈韵岱,王长华.急性心肌梗死经皮冠状动脉介入治疗术后无复流的防治进展[J].中国循环杂志,2010,25(3):165-166. 被引量:42
  • 3Qing Mei Wang, Timothy J Stalker, Yulan Gong, et al. Inhibition of Rho-kinase attenuates endothelial-leukocyte interaction during ischemia-reperfusion injury[J]. Vasc Med, 2012,17 : 379. 被引量:1
  • 4Masahiro Mohri, Hiroaki Shimokawa, Yoji Hirakawa. Rho-Kinase Inhibition With Intracoronary Fasudil Prevents Myocardial Ische- mia in Patients With Coronary Microvascular Spasm[J]. JACC, 2003,41(1) :15. 被引量:1
  • 5French JK,Ellis CJ,Webber BJ, et al. Abnormal coronary flow in infarct arteries 1 year after myocardial infarction is predicted at 4 weeks by corrected TIMI frame countand stenosis severity[J]. Am J Cardiol, 1998,81 : 665. 被引量:1
  • 6Vafft Hof AW, Liem A, Suryapranata H, eta. Angiographic as- sessment of myocardial reperfusion in patients treated with prima- ry angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group[J]. Circulation, 1998,97(23) : 2302. 被引量:1
  • 7Cibson CM,Cannon CP,Murphy SA, et al. Relationship of TIMI myocardial perfuion grade to mortality after administration of thrombolytic drugs[J]. Circulation , 2000,101 : 125. 被引量:1
  • 8Sanz-Rosa D, Garcia-Prieto J, Ibanez B. The future Therapy of myocardial protection[J]. Ann NY Acad Sci, 2012,1254 : 90. 被引量:1
  • 9Zhi-hui Jiang,Tian-tian Zhang,Jun-feng Zhang. Protective effects of fasudil hydrochloride post-conditioning on acute myocardial is- chemia/reperfusion injury in rats[J]. Cardiology Journal, 2013,20 (2) :197. 被引量:1
  • 10潘娜娜,谭丽娟,马建英.法舒地尔对心肌急性梗死大鼠心肌组织Bc1-2和Bax表达及血流动力学功能影响[J].青岛大学医学院学报,2010,46(2):128-131. 被引量:5

二级参考文献27

  • 1张曼,王文刚,曾定尹.法舒地尔对心力衰竭大鼠血流动力学和心肌细胞内钙离子浓度的影响[J].中国新药与临床杂志,2006,25(1):33-36. 被引量:17
  • 2BALDI A, ABBATE A, BUSSANI R, et al. Apoptosis and postinfarction left ventricular remodeling[J].J Mol Cell Cardiol, 2002,,34 (2) : 165-174. 被引量:1
  • 3TIYYAGURA S R, HNNEY S P. Left ventrieular remodeling after myocardial infarction: past, present, and future[J]. Mt Sinai J Med, 2006(6) :840-851. 被引量:1
  • 4ABBATEA A, SALLOUM F N, VECIL E, et al. Anakinra, a recombinant human interleukin 1 receptor antagonist, inhibits apoptosisin experimental acute myocardial infarction[J]. Circulation, 2008,117(20) : 2670-2683. 被引量:1
  • 5SHI J J, WEI L. Rho kinase in the regulation of cell death and survival[J]. Arch Immunol Ther Exp (Warsz ) , 2007,55(2) : 61-75. 被引量:1
  • 6DEL RE D P, MIYAMOTO S, BROWN J H. RhoA/Rho kinase up-regulate Bax to activate a mitochondrial death pathway and induce cardiomyocyte apoptosis[J]. J Biol Chem, 2007, 282(11) : 8069-8078. 被引量:1
  • 7Topoi EJ,Yadav JS.Recognition of the importance of embolization in athemsclerotic vascular disease[J].Circulation,2000;101:570-80. 被引量:1
  • 8Eeckhout E,Kern MJ.The coronary no-reflow phenomenon:a review of mechanisms and therapies[J].Eur Heart J,2001;22:729-39. 被引量:1
  • 9Jeong JH,Chun KJ,Park YH,et al.Safety of tirofiban therapy in Korean patients with acute coronary syndrome[J].Circ J,2005;69:650. 被引量:1
  • 10Montalescot G,Barragan P,Wittenbery O,et al.For the ADMIRAL investigators.Platelet glycopretionⅡb /Ⅲa inhibition with coronary stenting for acute myocardial infarction[J].N Eng J Med,2001;21:1895-903. 被引量:1

共引文献51

同被引文献11

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部